Loading…

Biological Activities of Phenolics from the Fruits of Phyllanthus emblica L. (Euphorbiaceae)

Seven phenolic compounds, 1 – 7, including a new organic acid gallate, mucic acid 1‐ethyl 6‐methyl ester 2‐O‐gallate (7), were isolated from the MeOH extract of the fruits of Phyllanthus emblica L. (Euphorbiaceae). The structures were elucidated on the basis of extensive spectroscopic analysis and c...

Full description

Saved in:
Bibliographic Details
Published in:Chemistry & biodiversity 2017-12, Vol.14 (12), p.n/a
Main Authors: Zhang, Jie, Miao, Dan, Zhu, Wan‐Fang, Xu, Jian, Liu, Wen‐Yuan, Kitdamrongtham, Worapong, Manosroi, Jiradej, Abe, Masahiko, Akihisa, Toshihiro, Feng, Feng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Seven phenolic compounds, 1 – 7, including a new organic acid gallate, mucic acid 1‐ethyl 6‐methyl ester 2‐O‐gallate (7), were isolated from the MeOH extract of the fruits of Phyllanthus emblica L. (Euphorbiaceae). The structures were elucidated on the basis of extensive spectroscopic analysis and comparison with literature data. Upon evaluated for their antioxidant abilities by 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH), 2,2′‐azinobis(3‐ethylbenzthiazoline‐6‐sulfonic acid) (ABTS), and ferric reducing antioxidant power (FRAP) assays. The inhibitory activities against melanogenesis in B16 melanoma cells induced by α‐MSH, as well as cytotoxic activities against four human cancer cell lines were also evaluated. All phenolic compounds, 1 – 7, exhibited potent antioxidant abilities (DPPH: IC50 5.6 – 12.9 μm; ABTS: 0.87 – 8.43 μm Trolox/μm; FRAP: 1.01 – 5.79 μm Fe2+/μm, respectively). Besides, 5 – 7, also exhibited moderate inhibitory activities against melanogenesis (80.7 – 86.8% melanin content), even with no or low toxicity to the cells (93.5 – 101.6% cell viability) at a high concentration of 100 μm. Compounds 1 – 3 exhibited cytotoxic activity against one or more cell lines (IC50 13.9 – 68.4%), and compound 1 with high tumor selectivity for A549 (SI 3.2).
ISSN:1612-1872
1612-1880
DOI:10.1002/cbdv.201700404